← Leaderboards
Erin Forbes Simonds
Soteria Biotherapeutics, Inc.
$299,600
Attributed
$299,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,600 · 1
By mechanism
R43$299,600 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentAdverse EventAntibodiesBackBaseB-Cell LeukemiaB Cell TherapyBcl2 GeneBenchmarkingBindingBiochemicalBiologicalBiological ImmunotherapyBiological Response Modifier TherapyBiologyBispecific AntibodiesBi-Specific T Cell EngagerB-LymphocytesB Lymphoid MalignancyCancer TherapyCancer TypeCd19 GeneCd3 AntigensAcute Lymphocytic Leukemia